This is a the United States news story, published by The Times & The Sunday Times, that relates primarily to Ozempic news.
For more the United States news, you can click here:
more the United States newsFor more Ozempic news, you can click here:
more Ozempic newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from The Times & The Sunday Times, you can click here:
more news from The Times & The Sunday TimesOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
obesity. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest semaglutide breakthrough news, significant weight loss news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
semaglutide drugsThe Times & The Sunday Times
•
70% Informative
In 2023 something very strange happened in the United States . The adult obesity rate, which had tripled since the 1980s , appeared to fall.
The strongest candidates are the drugs Ozempic and Wegovy , two “semaglutide’s medications that have helped people with obesity achieve significant weight loss.
In the past few years , the global appetite for these drugs has been remarkable but in the US their uptake has been particularly dramatic.
The NHS is backlogged and crippled by current healthcare costs, many of which are driven by obesity.
The cost of obesity to the NHS in 2021 was 11.4 billion — 8 per cent of the health service’s budget.
Productivity losses due to obesity are thought to cost the economy a further 8.9 billion a year.
Given the problems that Britain faces, that is an opportunity we cannot ignore. Daniel Susskind is an economist at Oxford University .
VR Score
79
Informative language
82
Neutral language
52
Article tone
informal
Language
English
Language complexity
51
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links